期刊文献+

顺式阿曲库铵和罗库溴铵在老年患者中的药效学比较 被引量:1

Pharmacodynamics of cisatracurium and rocuronium in elderly patients
原文传递
导出
摘要 目的:观察单次静脉注射不同剂量的顺式阿曲库铵在老年患者中的药效学变化,并与壮年患者和罗库溴铵比较,为顺式阿曲库铵在老年患者麻醉中的应用提供参考。方法:择期全麻乳腺手术患者100例,根据年龄分为老年组(Ⅰ组)和壮年组(Ⅱ组),每组再分成4个亚组:罗库溴铵组(Ⅰ1,Ⅱ1)、顺式阿曲库铵2×ED95组(Ⅰ2,Ⅱ2),3×ED95组(Ⅰ3,Ⅱ3)和4×ED95(Ⅰ4,Ⅱ4),共8组。肌肉松弛监测采用4个成串刺激(train-of-four,TOF)。肌肉松弛效应观察指标包括:起效时间、TOF无反应期、T1恢复到25%,50%和75%的时间以及恢复指数。结果:老年组顺式阿曲库铵的起效时间稍长于壮年组,但差异无统计学意义;老年组顺式阿曲库铵的TOF无反应期、T1恢复到25%,50%和75%的时间及恢复指数均稍长于壮年组,但差异无显著性。老年组罗库溴铵起效时间明显长于其壮年组(P<0.05),且老年组肌肉松弛效应恢复的各项参数也均明显长于壮年组(P<0.05)。顺式阿曲库铵的肌松恢复指数在各组之间的差异无统计学意义。结论:对于女性而言,增龄对单次静脉注射顺式阿曲库铵的药效学无明显影响,对单次静脉注射罗库溴铵的药效学有显著影响。 Objective: To compare the pharmacodynamic profiles of different doses of cisatracurium and rocuronium in elderly and young patients.Methods: One hundred patients undergoing elective surgery were randomly divided into two groups according to age difference: elderly(I) and young(II) groups.The two groups were then divided into four subgroups: rocuronium(I1,II1),cisatracurium 2×ED95 group(I2,II2),cisatracurium 3×ED95 group(I3,II3),cisatracurium 4×ED95 group(I4,II4).Neuromuscular blocking effects were monitored using Biometer accelograph.Train-of-four(TOF,with 0.2ms square wave at frequency of 2Hz,every 12s) stimulation was applied.The onset time,duration of TOF's unavailability,times of T1 recovered to 25%,50%,75% and recovery index were observed.Results: The action onset and duration after cisatracurium injection were little but not significantly longer in elderly patients than those in young patients.The action onset and pharmacodynamic recovery parameters after rocuronium injection in elderly patients were significantly longer than those in young patients(P〈0.05).The recovery index of cisatracurium in each group was not different.Conclusion: For women,aging has no influence on the pharmacodynamics of single injection of cisatracurium,while it influences that of single injection of rocuronium.
作者 任晓燕 马虹
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第10期900-904,共5页 Chinese Journal of New Drugs
关键词 顺式阿曲库铵 罗库溴铵 药效学 老年麻醉 cisatracurium rocuronium pharmacodynamics geriatric anesthesia
  • 相关文献

参考文献20

  • 1JOHN JS, HUGH D,HERMANN M, et al. The pharmacodynamics of cisatracurium in healthy adults[J]. Curr Opinion Anesthesiol, 1996, 9(Suppl 1) :S16 -S22.
  • 2LIEN CA, BELMONT MR, ABALOS A, et al. The cardiovascular effects and histamine-releasing properties of 51 W89 in patients receiving nitrous oxlde/opioid/barhlturate anesthesia [ J ]. Anesthesiology, 1995, 82(5) : 1131 - 1138.
  • 3闻大翔,蒋茹,杭燕南,王珊娟,孙大金.顺式阿曲库铵、维库溴铵在老年患者中的药效学研究[J].中华老年医学杂志,2004,23(5):313-315. 被引量:25
  • 4闻大翔,陈锡明,杭燕南,孙大金.顺式阿曲库铵在肾移植麻醉中的药效学研究[J].上海第二医科大学学报,2002,22(6):517-519. 被引量:24
  • 5COOPER R, MIRAKHUR RK, CLARKER RSJ, et al. Comparision of intubating after administration of org9426 ( rocuronium ) and suxamerhonium[J]. Br J Anaesth, 1992, 69( 1 ) : 269 - 273.
  • 6夏中元,郑利民,吴述轩.罗库溴铵合用维库溴铵时肌松效应及插管条件[J].中国新药杂志,1999,8(7):475-476. 被引量:4
  • 7KISOR DF, WARGIN WA,SCHMITH VD, et al. Organ-nondependent Hofmann elimination is the maigor clearance pathway of the neuromuscular blocking agent 51W89 in man [ J]. Pharm Res, 1994, 11(4): S335-S339.
  • 8BODY AH, EASTWOOD NB, PARKER CJR, et al. Phannacodynamics of the I R cis-1'R cis isomer of Atracurium(51W89) in health and renal failure [ J ]. Anesthesiology, 1995, 74 (3) : 400 - 404.
  • 9SZTARK F, CANTINI O, BOURDALLE-BADIE C, et al. Continuous infusion of cisatracurium in patients with renal dysfunction [ J]. Anesthesiology, 1999, 91 (4) : A1037 - AI041.
  • 10AHUJA TS, FREEMAN D,MAHNKEN JD, et al. Predictor of the development of hyperkalemia in patients using angiotensin- converting enzyme inhibitors[ J]. Am J Nephrol, 2000, 20(5) : 268 - 272.

二级参考文献39

  • 1郑武飞.实用临床免疫学技术[M].北京:人民卫生出版社,1987.186.
  • 2Rosow CE, Basta SJ, Savarese JJ, et al. Correlation of cardiovascular effects with increases in plasma histamineC J]. Anesthesiology,1980, 53 : S270.
  • 3Verburg KM, Bowsher RR, Henry DP. A new radioenzymatic assay for histamine using purified histamine N-methyltransferase [ J ]. Life Scienses, 1983, 32:2855 -2867.
  • 4Moss J. Muscle relaxants and histamine release[ J]. Acta Anaesthesiol Scand, 1995, 106 (Suppl) : 7 - 12.
  • 5Belmont MR, Lien CA, Quassy S, et aL The clinic neuromuscular pharmacology of 51 W89 in patients receiving nitrous oxide/opioid/barbiturate anaesthesia [ J ]. Anesthesiology, 1995, 82:1139 -1145.
  • 6Litdejohn IH, Abhay K, El Sayed PJ. Intubating conditions following 1R cis -1' R cis atracurium (51W89) [ J ]. Anaesthesia, 1995,50:499 - 502.
  • 7Boyd AH, Eastwood, NB, Parker CJR, et al. Pharmaco - dynamics of the 1R cis - 1' R cis isomer of atracurium ( 51 W89 ) in health and chronic renal failure[J]. Br J Anaesth, 1995, 74:400 -404.
  • 8Basta S J, Savarese JJ, Ali HH, et al. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine [ J]. Br J Anaesth, 1983, 55:105S-106S.
  • 9Watkins J. Histamine release by atracurium [ J ]. Br J Anaesth,1986,58 : 19S - 22S.
  • 10Scott RPF, Savarese JJ, Basta SJ, et al. Atmcurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response[ J]. Br J Anaesth, 1985, 57:550 - 553.

共引文献120

同被引文献10

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部